References
- INSP. Metodologia de supraveghere regionala a febrei hemoragice cu sindrom renal de etiologie hantavirala. [Romanian] https://www.cnscbt.ro/index.php/metodologii/infectia-cu-hantavirus/476-metodologie-de-supravegherea-infectiei-cu-hantavirusuri-2012
- Akram SM, Mangat R, Huang B. Hantavirus Cardiopulmonary Syndrome. http://www.ncbi.nlm.nih.gov/books/NBK459378
- Tortosa F, Carrasco G, Gallardo D, et al. Prognostic factors for cardio-pulmonary syndrome and death by hantavirus Andes Sur: cohort study in San Carlos de Bariloche and health influence area. Medicina (B Aires). 2022;82:351–360.
- Saggioro FP, Rossi MA, Duarte MIS, et al. Hantavirus Infection Induces a Typical Myocarditis That May Be Responsible for Myocardial Depression and Shock in Hantavirus Pulmonary Syndrome. J Infect Dis. 2007;195:1541–1549. doi: 10.1086/513874.
- Llah ST, Mir S, Sharif S, Khan S, Mir MA. Hantavirus induced cardiopulmonary syndrome: A public health concern. J Med Virol. 2018;90:1003–1009. doi: 10.1002/jmv.25054.
- Manigold T, Vial P. Human hantavirus infections: epidemiology, clinical features, pathogenesis and immunology. https://smw.ch/index.php/smw/article/view/1844
- Sanna G, Piras S, Madeddu S, et al. 5,6-Dichloro-2-phenylbenzotriazoles: New Potent Inhibitors of Orthohantavirus. Viruses. 2020;12:122. doi: 10.3390/v12010122.